BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou B, Yuan Y, Shi L, Hu S, Wang D, Yang Y, Pan Y, Kong D, Shikov AN, Duez P, Jin M, Li X, Hu X. Creation of an Anti-Inflammatory, Leptin-Dependent Anti-Obesity Celastrol Mimic with Better Druggability. Front Pharmacol 2021;12:705252. [PMID: 34526895 DOI: 10.3389/fphar.2021.705252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chang YH, Hung HY. Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review. Eur J Med Chem 2022;237:114405. [PMID: 35489224 DOI: 10.1016/j.ejmech.2022.114405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Marreddy RKR, Picker J, Phelps GA, Powell R, Cherian PT, Bowling JJ, Stephan CC, Lee RE, Hurdle JG. The licorice metabolite enoxolone attenuates Clostridioides difficile pathophysiology by corrupting its metabolic and toxin production networks.. [DOI: 10.1101/2022.04.20.488993] [Reference Citation Analysis]